If one examines immunologically mediated diseases where IFNγ plays a pathological role such as Wegener’s granulomatosis and systemic lupus erythematosus, one must consider the level of free IL-18 compared to IL-18 bound to IL-18BP. This evidence concerns the gene IL18 and systemic lupus erythematosus.